140 related articles for article (PubMed ID: 9125273)
1. Hypotensive effects of the angiotensin II antagonist telmisartan in conscious chronically-instrumented transgenic rats.
van Meel JC; Redemann N; Haigh RM
Arzneimittelforschung; 1996 Aug; 46(8):755-9. PubMed ID: 9125273
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
[TBL] [Abstract][Full Text] [Related]
6. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
7. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
Wagner J; Drab M; Bohlender J; Amann K; Wienen W; Ganten D
Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
[TBL] [Abstract][Full Text] [Related]
8. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
10. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.
Gohlke P; Weiss S; Jansen A; Wienen W; Stangier J; Rascher W; Culman J; Unger T
J Pharmacol Exp Ther; 2001 Jul; 298(1):62-70. PubMed ID: 11408526
[TBL] [Abstract][Full Text] [Related]
11. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Schnecko A; Witte K; Lemmer B
J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
[TBL] [Abstract][Full Text] [Related]
12. WB1106, a novel nitric oxide-releasing derivative of telmisartan, inhibits hypertension and improves glucose metabolism in rats.
Li YQ; Ji H; Zhang YH; Shi WB; Meng ZK; Chen XY; Du GT; Tian J
Eur J Pharmacol; 2007 Dec; 577(1-3):100-8. PubMed ID: 17822696
[TBL] [Abstract][Full Text] [Related]
13. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II antagonists DuP 753 and TCV 116.
Brunner HR; Delacrétaz E; Nussberger J; Burnier M; Waeber B
J Hypertens Suppl; 1994 Nov; 12(9):S29-34. PubMed ID: 7884581
[TBL] [Abstract][Full Text] [Related]
16. Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats.
Wienen W; Schierok HJ
J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):123-8. PubMed ID: 11881111
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
Maillard MP; Perregaux C; Centeno C; Stangier J; Wienen W; Brunner HR; Burnier M
J Pharmacol Exp Ther; 2002 Sep; 302(3):1089-95. PubMed ID: 12183667
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions.
Böhm M; Lee M; Kreutz R; Kim S; Schinke M; Djavidani B; Wagner J; Kaling M; Wienen W; Bader M
J Hypertens; 1995 Aug; 13(8):891-9. PubMed ID: 8557967
[TBL] [Abstract][Full Text] [Related]
20. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
